Consensus Cerenis Therapeutics LIQUIDNET SYSTEMS

Equities

FR0012616852

Real-time Estimate Cboe Europe Other stock markets 03:20:48 2024-07-12 am EDT			5-day change	1st Jan Change
1.232 ^EUR	0.00%		0.00%	0.00%

Jul. 01	Abionyx Pharma: successful capital increase	CF
Jun. 14	Abionyx: positive response from FDA, share price rises	CF

Evolution of the average Target Price on Cerenis Therapeutics

Price target over the last 5 years

History of analyst recommendation changes

27712b4818fe78.La0FcYnK-4ehnHN67G09_iRm66NlEubUIYZiXaoXPp8.G_RmAu-uj-zZ0R9LhipZq0gW29oRWJG-UO8SZZ17U9NpnnxE3I2Wy8nlGA~72d7366cf01881d3a145212ecd9f2fef

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

1.24 EUR

Average target price

11.5 EUR

Spread / Average Target

+827.42%

High Price Target

11.5 EUR

Spread / Highest target

+827.42%

Low Price Target

11.5 EUR

Spread / Lowest Target

+827.42%

Consensus detail

Consensus revision (last 18 months)

Ratings for Cerenis Therapeutics

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar